Skip to content
Search

Latest Stories

CPCF negotiations conclude: Funding details expected Monday, says CPE

The government and NHS have published their economic analysis into community pharmacy funding, which has informed CPCF negotiations.

CPCF negotiations conclude: Funding details expected Monday, says CPE

Community pharmacy funding

Community Pharmacy England (CPE) has confirmed the conclusion of Community Pharmacy Contractual Framework (CPCF) negotiations, with funding details for the year ahead expected to be announced on Monday, 31 March.

CPE welcomed the findings of the independent analysis into community pharmacy funding, which played a key role in informing the negotiations.


“We are pleased that the government and NHS have published their Economic Analysis, which has informed CPCF negotiations and which they committed to being fully transparent about,” a CPE spokesperson said.

“The analysis underlines the critical pressures that pharmacies are under, as we have been warning for many years.”

The spokesperson added: “Now that CPCF negotiations have concluded we are working urgently to share full news and details about the year ahead with the sector – timings are dictated by Government, but this is scheduled to happen on Monday.”

CPE stresses that this is “an extremely anxious time for pharmacy owners.”

Nick Kaye, chair of the National Pharmacy Association (NPA), responded to the conclusion of CPCF negotiations, stating: "Pharmacies will be deeply relieved to have certainty about their financial position.”

"We’ll look carefully at the detail and consult with our members to understand what this means for their sustainability before issuing further advice.”

Kaye also acknowledged the significant challenges ahead.

"As the independent economic analysis has laid bare, the government have inherited an intolerable situation and have a mountain to climb to address the unprecedented challenges facing pharmacies across the country,” he said.

The long-awaited independent analysis into community pharmacy funding, carried out by Frontier Economics and commissioned by NHS England, found that 78 per cent of pharmacies in England are not sustainable in the short term.

Around 47 per cent of pharmacies were not profitable in their last accounting year and almost all pharmacies had funding which was lower than full economic cost.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less